TScan Therapeutics
Sonal Jangalwe, Ph.D., is an accomplished immunologist with extensive experience in the fields of biotechnology and immunotherapy. Currently serving as Associate Director at TScan Therapeutics since June 2019, Sonal Jangalwe has held multiple positions, including Principal Scientist in New Technology & Product Development and Preclinical roles. Prior to this, Sonal Jangalwe worked as a Postdoctoral Fellow at UMass Medical School, focusing on humanized mouse models to study immunity and cancer treatments. Previous experience includes a postdoctoral role at Pfizer-Rinat, where Sonal Jangalwe aimed to enhance CAR T cell persistence through advanced genetic modifications. Sonal Jangalwe's academic background includes a Ph.D. in Immunology from UMass Chan Medical School and a Master's in Biotechnology from Savitribai Phule Pune University.